HALO 74.93 ▲ 2.08% Live Trading Data - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Halozyme Therapeutics Inc...

    NASDAQ: HALO · Real-Time Price · USD
    74.93
    1.53 (2.08%)
    At close: Sep 05, 2025, 3:59 PM
    74.87
    -0.08%
    After-hours: Sep 05, 2025, 07:31 PM EDT
    2.08%
    Bid 72.08
    Market Cap 8.76B
    Revenue (ttm) 1.18B
    Net Income (ttm) 557.28M
    EPS (ttm) 4.37
    PE Ratio (ttm) 17.15
    Forward PE 9.4
    Analyst Buy
    Ask 75
    Volume 1,828,382
    Avg. Volume (20D) 2,190,559
    Open 73.81
    Previous Close 73.40
    Day's Range 72.39 - 74.96
    52-Week Range 42.01 - 75.46
    Beta 1.20

    About HALO

    undefined

    [Read more]
    Industry n/a
    Sector n/a
    IPO Date n/a
    Employees NaN
    Stock Exchange n/a
    Ticker Symbol HALO
    Website n/a
    Full Company Profile

    Analyst Forecast

    According to 0 analyst ratings, the average rating for HALO stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

    Stock Forecasts

    Next Earnings Release

    Halozyme Therapeutics Inc. is scheduled to release its earnings on Oct 30, 2025, during market hours.
    Analysts project revenue of ... Unlock content with Pro Subscription
    1 month ago
    +2.48%
    Halozyme shares are trading higher after the compa... Unlock content with Pro Subscription
    1 month ago
    +1.37%
    Halozyme shares are trading higher after the company raised FY25 guidance.
    news image

    1 day ago · zacks.com

    Bet on These 3 Stocks With Upgraded Broker Ratings for Robust Returns

    Broker upgrades boost Halozyme, Leidos and TransUnion, each projected for solid 2025 earnings growth and stronger returns.

    news image

    3 days ago · seekingalpha.com

    Halozyme Therapeutics, Inc. (HALO) Presents At Wells Fargo 20th Annual Healthcare Conference 2025 Prepared Remarks Transcript

    Halozyme Therapeutics, Inc. (NASDAQ:HALO ) Wells Fargo 20th Annual Healthcare Conference 2025 September 4, 2025 1:30 PM EDT Company Participants Helen Torley - President, CEO & Director Conference Cal...

    news image

    2 days ago · zacks.com

    4 PEG-Rated GARP Stocks That Offer Both Value and Growth

    Halozyme, Phibro, Leidos and PDD Holdings stand out as PEG-rated GARP picks, blending value and growth with solid long-term potential.

    news image

    4 days ago · zacks.com

    Are You Looking for a Top Momentum Pick? Why Halozyme Therapeutics (HALO) is a Great Choice

    Does Halozyme Therapeutics (HALO) have what it takes to be a top stock pick for momentum investors? Let's find out.

    news image

    3 days ago · zacks.com

    Best Momentum Stock to Buy for September 3rd

    HALO, TROW and CARS made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on September 3, 2025.

    news image

    3 days ago · zacks.com

    Are Medical Stocks Lagging Halozyme Therapeutics (HALO) This Year?

    Here is how Halozyme Therapeutics (HALO) and atai Life Sciences N.V. (ATAI) have performed compared to their sector so far this year.

    news image

    3 days ago · zacks.com

    Halozyme Therapeutics, Inc. (HALO) Hit a 52 Week High, Can the Run Continue?

    Halozyme Therapeutics (HALO) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

    news image

    3 days ago · zacks.com

    New Strong Buy Stocks for September 3rd

    TDW, JRVR, HALO, SCSC and CSW have been added to the Zacks Rank #1 (Strong Buy) List on September 3, 2025.

    news image

    1 week ago · fxempire.com

    Identify Superstar Stocks Like Halozyme with Money Flows

    Halozyme Therapeutics, Inc. (HALO) shares up 491% since first Big Money outlier inflow signal in March 2014.

    news image

    1 week ago · zacks.com

    Here's Why Halozyme Therapeutics (HALO) is a Strong Momentum Stock

    Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

    Add to Watchlist